AMN Healthcare Services, Inc. (AMN)

NYSE: AMN · USD

$46.6

-0.18 (-0.4%)· Recorded snapshot

Market cap	1.8B
Revenue (ttm)	3.4B
Net income (ttm)	104.9M
EPS (ttm)	$2.69
Shares out	38.7M
P/E (trailing)	17.3x
P/E (forward)	54.9x
Volume	762,879
Beta	0.40

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3.4B
Net income (ttm): 104.9M
EPS (ttm): $2.69
P/E (trailing): 17.3x
P/E (forward): 54.9x
Market cap: 1.8B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	보유

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E54.9

P25 n/aP50 n/aP75 n/a

Trailing P/E17.3

P25 n/aP50 n/aP75 n/a

ROE15.6

P25 n/aP50 n/aP75 n/a

ROIC9.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All AMN indicators

Market & fundamental data

Available fields

267

Groups with data

Currency

USD

Showing 267 of 267 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001142750
Company name	AMN Healthcare Services, Inc.
Country	United States
Country code	US
CUSIP number	001744101
Earnings date	2026-11-05
Earnings time	amc
Employees	2,664
Employees change	-304
Employees growth	-10.24%
Enterprise value	$2.2B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1985
In index	RUSSELL2000
Industry	Medical Care Facilities
IPO date	2001-11-13
Is primary listing	Yes
Is SPAC	No
ISIN number	US0017441017
Last 10-K release date	2026-02-20
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$1.8B
Market cap category	Small-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$46.63
Price currency	USD
Sector	Healthcare
SIC code	7363
Stock price date	2026-10-28
Symbol	AMN
U.S. state	Texas
Website	https://www.amnhealthcare.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	13.4x
Average P/E ratio (10Y)	19.27x
Average P/E ratio (5Y)	15.02x
Earnings yield	5.77%
EV/Earnings	21.48x
EV/EBIT	14.02x
EV/EBITDA	7.33x
EV/FCF	5.13x
EV/Sales	0.66x
FCF / EV yield	19.49%
FCF yield	23.87%
Forward EV/Sales	0.86x
Forward P/E	54.92x
Forward P/S	0.7x
Graham number	34.05075
Graham upside	-28.3%
Industry forward P/E	14.95x
Industry P/E	18.37x
Lynch fair value	$13.46
Lynch upside	-71.66%
P/(FCF - SBC) ratio	4.54x
P/(OCF - SBC) ratio	4.21x
P/B ratio	2.44x
P/E ratio	17.33x
P/FCF ratio	4.19x
P/OCF ratio	3.91x
P/S ratio	0.54x
PEG ratio	6.29x
Price/EBITDA ratio	5.99x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	4.68%
EBITDA margin	8.95%
Effective tax rate	36.1%
FCF margin	12.79%
Gross margin	27.79%
Operating margin	4.68%
Pretax margin	4.78%
Profit margin	3.05%
Profit per employee	$39,384
Profitable quarters	2
Revenue per employee	$1.3M
ROA	4.39%
ROA (5Y)	7.1%
ROCE	10.08%
ROE	15.56%
ROE (5Y)	12.5%
ROIC	9.85%
ROIC (5Y)	13.26%
SBC / revenue	0.99%
Tax / revenue	1.73%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (QoQ)	-66.67%
EPS growth 10Y	2.24%
EPS growth 3Y	-29.19%
EPS growth 5Y	-5.68%
EPS growth quarters	4
EPS growth years	1
FCF growth	71.88%
FCF growth 3Y	4.83%
FCF growth 5Y	8.05%
Gross profit growth	15.45%
Gross profit growth (Q)	4.83%
Gross profit growth 3Y	-13.2%
Gross profit growth 5Y	-0.15%
Net income growth (QoQ)	-65.96%
Net income growth 3Y	-30.99%
Net income growth 5Y	-9.47%
Net income growth quarters	4
Net income growth years	1
OCF growth	51.5%
OCF growth 10Y	19.71%
OCF growth 3Y	0.04%
OCF growth 5Y	6.78%
Operating income growth	173.6%
Operating income growth (Q)	562.43%
Operating income growth 3Y	-30.17%
Operating income growth 5Y	-10.55%
Revenue growth	23.99%
Revenue growth (Q)	2.29%
Revenue growth (QoQ)	-51.16%
Revenue growth 10Y	7.12%
Revenue growth 3Y	-7.8%
Revenue growth 5Y	3.25%
Revenue growth quarters	3
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-31.6M
Depreciation and amortization	$146.6M
EBIT	$160.7M
EBITDA	$307.3M
EPS	$2.69
FCF per share	$11.34
Financing cash flow	$-184M
Free cash flow	$439.1M
Free cash flow minus SBC	$405M
Gross profit	$954.3M
Income taxes	$59.3M
Investing cash flow	$31.2M
Net borrowing	$-170M
Net cash flow	$318M
Net income	$104.9M
Operating cash flow minus SBC	$436.6M
Operating income	$160.7M
Revenue	$3.4B
Stock-based compensation	$34.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.78
Book value per share	$19.15
Debt / EBITDA	2.43
Debt / equity	1.05
Debt / FCF	1.77
Goodwill	$759M
Interest coverage	4.51
Long-term assets	$1.5B
Long-term liabilities	$852.2M
Net cash (debt)	$-414M
Net cash / market cap	-22.51%
Net debt / EBITDA	1.35
Net debt / equity	0.56
Net debt / FCF	0.94
Piotroski F-Score	7
Property, plant and equipment	$141.8M
Shareholders' equity	$741.3M
Tangible book value	$-267.8M
Tangible book value per share	$-6.92
Total assets	$2.4B
Total cash	$361.8M
Total debt	$775.8M
Total liabilities	$1.6B
WACC	5.42%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.5
Current assets	$869.3M
Current liabilities	$770.5M
Current ratio	1.13
Net working capital	$-257.3M
Quick ratio	1.03
Working capital	$98.8M
Working capital turnover	71.2

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-2.07%
Dividend yield	0%
Shareholder yield	-2.07%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	46.73%
10Y return CAGR	3.91%
10Y total return	46.73%
150-day SMA	$31.05
15Y price change	805.44%
15Y return CAGR	15.82%
15Y total return	805.44%
1D price change	-0.38%
1M price change	34.93%
1M total return	34.93%
1W price change	8.42%
1W total return	8.42%
1Y price change	121.94%
1Y return CAGR	122.06%
1Y total return	121.94%
20-day SMA	$40.40
200-day SMA	$28.17
20Y price change	82.43%
20Y return CAGR	3.05%
20Y total return	82.43%
3M price change	39.4%
3M total return	39.4%
3Y price change	-38.4%
3Y return CAGR	-14.91%
3Y total return	-38.4%
50-day SMA	$36.73
50-day SMA vs 200-day SMA	50over200
52-week high	$49.62
52-week high date	2026-10-27
52-week low	$14.97
52-week low date	2026-01-05
5Y price change	-51.57%
5Y return CAGR	-13.5%
5Y total return	-51.57%
6M price change	122.26%
6M total return	122.26%
All-time high	$129.12
All-time high date	2021-12-27
All-time low	$3.60
All-time low date	2011-10-04
Average true range (ATR)	$1.85
Average volume	935.4K
Beta (1Y)	0.79
Beta (2Y)	0.68
Beta (5Y)	0.4
Change from 52-week high	-6.03%
Change from 52-week low	211.49%
Change from all-time high	-63.89%
Change from all-time low	1,195.28%
Change from open	0.43%
Day's gap	-0.81%
Dollar volume	$35.6M
High price	$48.12
Low price	$46.43
Monthly RSI	61.32
Open price	$46.43
Position in 52-week range	11.83%
Premarket change	-0.34%
Premarket close	$46.81
Premarket price	$46.65
Premarket volume	4.6K
Previous close	$46.81
Price vs 150-day SMA	50.17%
Price vs 20-day SMA	15.43%
Price vs 200-day SMA	65.55%
Price vs 50-day SMA	26.94%
Relative volume	0.82
RSI	74.64
Sharpe ratio	1.46
Sharpe ratio (3Y)	-0.03
Sharpe ratio (5Y)	-0.08
Sortino ratio	2.81
Sortino ratio (3Y)	0.06
Sortino ratio (5Y)	-0
Volume	762.9K
Weekly RSI	77.77
YTD price change	195.88%
YTD total return	195.88%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	38.3M
Float percentage	98.94%
Shares change (QoQ)	1.57%
Shares change (YoY)	2.07%
Shares held by insiders	1.01%
Shares held by institutions	120.07%
Shares outstanding	38.7M
Short % of float	9.41%
Short % of shares	9.31%
Short ratio	5.9 days

Deeper analysis on AMN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this AMN report

Is a complete AMN research report available?

No complete published report is available for AMN Healthcare Services, Inc. (AMN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

AMN Healthcare Services, Inc. (AMN)

Price

Financial snapshot

Fair-value bridge

Latest news · AMN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AMN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on AMN

Frequently asked questions